Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Healthcare ETF

72.38
+0.36000.50%
Post-market: 72.380.00000.00%19:30 EDT
Volume:3.32M
Turnover:240.07M
Market Cap:3.89B
PE:6.52
High:73.21
Open:72.93
Low:72.14
Close:72.02
52wk High:74.59
52wk Low:56.44
Shares:53.70M
Float Shares:53.70M
Volume Ratio:9.40
T/O Rate:6.18%
Dividend:0.81
Dividend Rate:1.12%
EPS(TTM):11.10
EPS(LYR):3.06
ROE:6.01%
ROA:0.87%
PB:1.39
PE(LYR):23.66

Loading ...

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Yesterday

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
Yesterday

Dow Jones Top Company Headlines at 5 PM ET: FTC Files Lawsuit Alleging Amazon Deceived Advertisers | State ...

Dow Jones
·
Yesterday

Ataibeckley - Hart-Scott-Rodino Waiting Period for Merger with Eli Lilly Expired on Aug 28, 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
Yesterday

Moderately bullish activity in Eli Lilly with shares down 1.26%

TIPRANKS
·
Yesterday

Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation

MT Newswires Live
·
Aug 31

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Aug 31

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
Aug 31

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live
·
Aug 31

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

Stock News
·
Aug 31

States Namenda Tablets not Withdrawn for Safety or Effectiveness Reasons - Federal Register

THOMSON REUTERS
·
Aug 31

FDA: Will not Begin Procedures to Withdraw Approval of Abbreviated New Drug Applications That Refer to Namenda Products - Federal Register

THOMSON REUTERS
·
Aug 31

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Aug 31

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31